Philip Morris International, a leading global tobacco company and manufacturer of innovative smoke-free products, has been recognized as a “Top Employer” in Egypt, Jordan, and Lebanon for the 8th consecutive year by the “Top Employers Institute”. The institute grants the award to leading organizations and institutions that demonstrate excellence in human resources practices and provide the best work environment for their employees.
The Top Employer Award marks organizations that successfully implement sustainability standards and policies and provide opportunities for progress and excellence for their employees, within a work environment that meets the needs for development and growth.
The Managing Director of Philip Morris Egypt and Levant, Ali N. Karaman, expressed his contentment for winning the award, saying: “The recognition of Philip Morris as a Top Employer for the 8th consecutive year manifests the company’s successful operational policy and our leadership as a global employer in providing the best workplace experience for our employees. We are proud of this award that marks the alignment of Philip Morris’s strategy and work policies with innovation and development goals.”
Karaman emphasized Philip Morris’s unwavering commitment towards investing in its people, recognizing them as the driving force behind the company’s success. He highlighted that empowered and thriving employees, supported by continuous development, are the bedrock of the company’s transformation towards a smoke-free future.
Philip Morris International:
Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. As of September 30, 2023, PMI’s smoke-free products were available for sale in 82 markets, and PMI estimates that approximately 19.7 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 36.2% of PMI’s total third-quarter 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences